Pharma Journalist - Page 875 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Seqirus Announces Next Major Advancement in Cell-Based Influenza Vaccine Technology

GSK wins $235 million from Teva in Coreg patent trial

Smithers Avanza adds three additional instruments to its bioanalytical laboratory

Almac Discovery and Debiopharm International SA Announce a Licensing Agreement

Discovery could guide immunotherapy for lung cancer

Innocrin Pharmaceuticals Granted SME Status Designation by the EMA

Nanotherapeutics appoints Peter H. Khoury as President and CEO

BlackThorn receives $8 Million to advance KOR Antagonist Program

NanoSphere Health Sciences Signs Binding Merger Agreement for 100% Acquisition by Corazon Gold Corp.

Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics